Wanyong Chen

784 total citations
20 papers, 540 citations indexed

About

Wanyong Chen is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Wanyong Chen has authored 20 papers receiving a total of 540 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 6 papers in Cancer Research and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Wanyong Chen's work include RNA modifications and cancer (7 papers), Ferroptosis and cancer prognosis (5 papers) and Cancer Mechanisms and Therapy (2 papers). Wanyong Chen is often cited by papers focused on RNA modifications and cancer (7 papers), Ferroptosis and cancer prognosis (5 papers) and Cancer Mechanisms and Therapy (2 papers). Wanyong Chen collaborates with scholars based in China, United States and Ethiopia. Wanyong Chen's co-authors include Ning Ren, Chenhao Zhou, Jialei Sun, Qiang Zhou, Manar Atyah, Yirui Yin, Qiongzhu Dong, Bo Hu, Qing‐Hai Ye and Haijun Zhou and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Wanyong Chen

20 papers receiving 536 citations

Peers

Wanyong Chen
Wanyong Chen
Citations per year, relative to Wanyong Chen Wanyong Chen (= 1×) peers Ketuan Huang

Countries citing papers authored by Wanyong Chen

Since Specialization
Citations

This map shows the geographic impact of Wanyong Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wanyong Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wanyong Chen more than expected).

Fields of papers citing papers by Wanyong Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wanyong Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wanyong Chen. The network helps show where Wanyong Chen may publish in the future.

Co-authorship network of co-authors of Wanyong Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Wanyong Chen. A scholar is included among the top collaborators of Wanyong Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wanyong Chen. Wanyong Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Chenhao, Weiya Xia, Yifan Zhou, et al.. (2024). Targeting ALK averts ribonuclease 1-induced immunosuppression and enhances antitumor immunity in hepatocellular carcinoma. Nature Communications. 15(1). 1009–1009. 9 indexed citations
2.
Atyah, Manar, Chenhao Zhou, Qiang Zhou, et al.. (2022). The Age-Specific Features and Clinical Significance of NRF2 and MAPK10 Expression in HCC Patients. SHILAP Revista de lepidopterología. 7 indexed citations
3.
Zhou, Qiang, Yirui Yin, Mincheng Yu, et al.. (2022). GTPBP4 promotes hepatocellular carcinoma progression and metastasis via the PKM2 dependent glucose metabolism. Redox Biology. 56. 102458–102458. 55 indexed citations
4.
Weng, Jialei, Chenhao Zhou, Qiang Zhou, et al.. (2021). Development and Validation of a Metabolic Gene-Based Prognostic Signature for Hepatocellular Carcinoma. SHILAP Revista de lepidopterología. Volume 8. 193–209. 5 indexed citations
5.
Zhou, Qiang, Chenhao Zhou, Yirui Yin, et al.. (2021). Development and validation of a nomogram combining hematological and imaging features for preoperative prediction of microvascular invasion in hepatocellular carcinoma patients. Annals of Translational Medicine. 9(5). 402–402. 11 indexed citations
6.
Sun, Jialei, Chenhao Zhou, Yue Zhao, et al.. (2021). Quiescin sulfhydryl oxidase 1 promotes sorafenib-induced ferroptosis in hepatocellular carcinoma by driving EGFR endosomal trafficking and inhibiting NRF2 activation. Redox Biology. 41. 101942–101942. 132 indexed citations
7.
Zhou, Chenhao, Chunxiao Liu, Wenjie Liu, et al.. (2020). SLFN11 inhibits hepatocellular carcinoma tumorigenesis and metastasis by targeting RPS4X via mTOR pathway. Theranostics. 10(10). 4627–4643. 76 indexed citations
8.
Zhou, Chenhao, Jialei Sun, Zhiyuan Zheng, et al.. (2020). High RPS11 level in hepatocellular carcinoma associates with poor prognosis after curative resection. Annals of Translational Medicine. 8(7). 466–466. 17 indexed citations
9.
Zhou, Chenhao, Jialei Weng, Chunxiao Liu, et al.. (2020). High RPS3A expression correlates with low tumor immune cell infiltration and unfavorable prognosis in hepatocellular carcinoma patients.. PubMed. 10(9). 2768–2784. 30 indexed citations
10.
Sun, Jialei, Chenhao Zhou, Wanyong Chen, et al.. (2019). High GCLC level in tumor tissues is associated with poor prognosis of hepatocellular carcinoma after curative resection. Journal of Cancer. 10(15). 3333–3343. 34 indexed citations
11.
Zhou, Chenhao, Shun Wang, Qiang Zhou, et al.. (2019). A Long Non-coding RNA Signature to Improve Prognostic Prediction of Pancreatic Ductal Adenocarcinoma. Frontiers in Oncology. 9. 1160–1160. 17 indexed citations
12.
Zhou, Chenhao, Yue Zhao, Yirui Yin, et al.. (2019). A robust 6-mRNA signature for prognosis prediction of pancreatic ductal adenocarcinoma. International Journal of Biological Sciences. 15(11). 2282–2295. 15 indexed citations
13.
Chen, Wanyong, Chenhao Zhou, Wentao Zhang, et al.. (2018). Association of WWOX rs9926344 polymorphism with poor prognosis of hepatocellular carcinoma. Journal of Cancer. 9(7). 1239–1247. 10 indexed citations
14.
Zhou, Chenhao, Wanyong Chen, Jialei Sun, et al.. (2018). Low expression of WW domain‐containing oxidoreductase associates with hepatocellular carcinoma aggressiveness and recurrence after curative resection. Cancer Medicine. 7(7). 3031–3043. 18 indexed citations
15.
Zhou, Chenhao, Wentao Zhang, Wanyong Chen, et al.. (2017). Integrated Analysis of Copy Number Variations and Gene Expression Profiling in Hepatocellular carcinoma. Scientific Reports. 7(1). 10570–10570. 34 indexed citations
16.
Guo, Lei, Shumin Zhang, Bo Zhang, et al.. (2016). Silencing GTSE-1 expression inhibits proliferation and invasion of hepatocellular carcinoma cells. Cell Biology and Toxicology. 32(4). 263–274. 37 indexed citations
17.
Fang, Guochang, et al.. (2008). Well-posedness of the Solution to D-P Equation with Dispersive Term. 3 indexed citations
18.
Wan, Jian, et al.. (2008). An Efficient Self-Healing Scheme for Wireless Sensor Networks. 98–101. 4 indexed citations
19.
Xu, Xianghua, et al.. (2008). Distributed fault diagnosis of wireless sensor networks. 148–151. 22 indexed citations
20.
Chen, Wanyong, et al.. (2000). Discovery of a Pliocene stone tool at Yuldan, Hebei Province. Chinese Science Bulletin. 45(4). 380–383. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026